| Not Yet Recruiting | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of SSS67 in Healthy Adult Particip Healthy | Phase 1 | 2026-03-31 |
| Not Yet Recruiting | The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patien NMIBC | Phase 1 / Phase 2 | 2026-03-12 |
| Not Yet Recruiting | A Phase II Clinical Study Evaluating SSGJ-706 in Combination Therapy for Advanced Gastrointestinal Cancers Gastric/Gastroesophageal Junction Adenocarcinoma, Metastatic Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) | Phase 2 | 2025-11-01 |
| Recruiting | A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） First-line Advanced NSCLC Patients | Phase 2 | 2025-10-24 |
| Recruiting | Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects Safety Issues | Phase 1 | 2025-08-04 |
| Recruiting | A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 | 2025-07-30 |
| Recruiting | SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors Locally Advanced, Recurrent or Metastatic Malignancies | Phase 2 | 2025-07-30 |
| Recruiting | A Phase I Study of SSGJ-612 in Patients With Advanced Solid Tumors Advanced Malignant Tumors | Phase 1 | 2025-07-18 |
| Not Yet Recruiting | Phase IIa Trial of Oral SSS17 for Post-Arthroplasty Anemia Postoperative Anemia, Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee | Phase 2 | 2025-07-01 |
| Recruiting | SSGJ-707 in Advanced Non-Small Cell Lung Cancer Advanced Non-Small Cell Lung Cancer | Phase 3 | 2025-06-20 |
| Recruiting | Phase I Study of HBT-708 for Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2025-06-16 |
| Recruiting | A Phase 1 Study of SSGJ-709 in Patients With Advanced Malignant Tumors Advanced Malignant Tumors | Phase 1 | 2025-06-12 |
| Not Yet Recruiting | A Phase 1 Mass Balance Study of [¹⁴C]SSS17 in Healthy Chinese Males Healthy Subjects (HS) | Phase 1 | 2025-06-01 |
| Recruiting | A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors Malignant Tumors | Phase 1 | 2025-04-27 |
| Completed | A Study Evaluating the Food Effect on the Pharmacokinetics of SSS17 Capsules in Chinese Healthy Subjects Healthy Subjects (HS) | Phase 1 | 2025-03-16 |
| Not Yet Recruiting | Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies Chemotherapy-induced Anemia, Non-myeloid Malignancies | Phase 2 | 2025-03-01 |
| Enrolling By Invitation | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subje Safety and Tolerability in Healthy Volunteers | Phase 1 | 2024-10-09 |
| Recruiting | Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain Cancer Pain | Phase 1 / Phase 2 | 2024-03-27 |
| Recruiting | Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia Gout, Hyperuricemia | Phase 1 | 2023-11-20 |
| Completed | Phase II Dose-Finding of Oral SSS17 for Anemia in Non-Dialysis CKD Anemia in Pre-Dialysis Patients | Phase 2 | 2023-03-01 |
| Unknown | A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Diseas Liver Disease Chronic, Thrombocytopenia | Phase 1 | 2022-01-16 |
| Unknown | A Phase 1 Study of SSS17 in Healthy Subjects. Anemia in Chronic Kidney Diseases | Phase 1 | 2021-07-26 |
| Unknown | Phase III Clinical Study of Recombinant Erythropoiesis Stimulating Protein Injection (rESP) in the Treatment o Kidney Failure, Chronic, Hemodialysis | Phase 3 | 2021-07-01 |
| Unknown | A Multi-site Bridging Study of Nalfurafine Hydrochloride Orally Disintegrating Tablet Uremic Pruritus | Phase 3 | 2020-09-07 |
| Unknown | A Study of SSS17 in Healthy Subjects Anemia in Chronic Kidney Diseases | Phase 1 | 2020-05-01 |
| Unknown | A Study to Determine the Safety, Tolerability, PK and Preliminary PD of SSS11 in Chinese Healthy Adult Volunte Gout | Phase 1 | 2019-10-22 |
| Unknown | Study of rESP Injection for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis Chronic Renal Failure With Hemodialysis | Phase 2 | 2019-06-24 |
| Unknown | The Tolerability，Safety，PK/PD Study of rhTPO in the Patients With Liver Function Impairment Liver Cirrhosis | EARLY_Phase 1 | 2018-06-28 |
| Unknown | A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects. Gout | Phase 1 | 2017-10-09 |
| Completed | Evaluating the Efficacy and Safety of Different Human Thrombopoietin (rhTPO) Regimens in the Treatment of Pati ITP | Phase 4 | 2016-12-01 |
| Completed | Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) Renal Anemia | Phase 3 | 2015-12-01 |
| Terminated | Biosimilar Erythropoietin in Anaemia Treatment (Correction Phase Study) Renal Anaemia | Phase 4 | 2015-08-01 |
| Completed | A Trial With Humanized TNFα Monoclonal Antibody Injection by Single Dose and Dose Escalation in Healthy Subjec Rheumatoid Arthritis | Phase 1 | 2015-05-01 |
| Unknown | rESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safe Chronic Renal Failure | Phase 1 | 2014-09-01 |
| Unknown | The Study of rHuTPO/rHuIL-11 in the Treatment for Chemotherapy-induced Thrombocytopenia in Patients With NSCLC Thrombocytopenia | — | 2009-05-01 |